Michael Edward Solomon's most recent trade in Protara Therapeutics Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protara Therapeutics Inc | Michael Edward Solomon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Michael Edward Solomon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Michael Edward Solomon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Michael Edward Solomon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Protara Therapeutics Inc | Michael Edward Solomon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |